Related references
Note: Only part of the references are listed.Drug-related adverse effects of vismodegib and sonidegib for locally advanced or metastatic basal cell carcinoma
Matthew Gibson et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2020)
Vismodegib for periocular basal cell carcinoma: an international multicentre case series
H. Oliphant et al.
EYE (2020)
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
Alessia Villani et al.
DERMATOLOGY AND THERAPY (2020)
Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma
Oded Sagiv et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
Efficacy of Vismodegib for the Treatment of Orbital and Advanced Periocular Basal Cell Carcinoma
Maya Eiger-Moscovich et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test
Alessia Villani et al.
DERMATOLOGY AND THERAPY (2019)
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients' Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI)
Alessia Villani et al.
DERMATOLOGY AND THERAPY (2019)
Follow-Up of Patients With Complete Remission of Locally Advanced Basal Cell Carcinoma After Vismodegib Discontinuation: A Multicenter French Study of 116 Patients
Florian Herms et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Neoadjuvant Vismodegib and Mohs Micrographic Surgery for Locally Advanced Periocular Basal Cell Carcinoma
Abel R. Gonzalez et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2019)
Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma
Oded Sagiv et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2019)
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study
J. T. Lear et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
An exploratory open- label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas
Duy Cong Tran et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Efficacy, safety, and comparison of sonic hedgehog inhibitors in basal cell carcinomas: A systematic review and meta-analysis
Pingxing Xie et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Combination vismodegib and photodynamic therapy for multiple basal cell carcinomas
Jason M. Rizzo et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2018)
Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell Carcinoma
Stefanie Fischer et al.
ONCOLOGY RESEARCH AND TREATMENT (2018)
Giant morphea-form basal cell carcinoma of the umbilicus: Successful debulking with vismodegib
Mariana Orduz Robledo et al.
RARE TUMORS (2018)
Methodological quality and synthesis of case series and case reports
Mohammad Hassan Murad et al.
BMJ EVIDENCE-BASED MEDICINE (2018)
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
N. Basset-Seguin et al.
EUROPEAN JOURNAL OF CANCER (2017)
Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease
Philip R. Cohen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Secondary Resistance to Vismodegib After Initial Successful Treatment of Extensive Recurrent Periocular Basal Cell Carcinoma with Orbital Invasion
Vasilios P. Papastefanou et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2017)
Pembrolizumab with or without vismodegib in treating metastatic or unresectable basal cell skin cancer.
Anne Lynn S. Chang et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Vismodegib for Locally Advanced Periocular and Orbital Basal Cell Carcinoma: A Review of 15 Consecutive Cases
Kai Yuen Wong et al.
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN (2017)
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Aleksandar Sekulic et al.
BMC CANCER (2017)
Hedgehog pathway inhibitor in combination with radiation therapy for basal cell carcinomas of the head and neck First clinical experience with vismodegib for locally advanced disease
Bjoern Schulze et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2016)
Vismodegib and surgery combined - effective treatment of locally advanced basal cell carcinoma
Jakob Felbo Paulsen et al.
ACTA ONCOLOGICA (2016)
Hedgehog Pathway Inhibitor Therapy for Locally Advanced and Metastatic Basal Cell Carcinoma A Systematic Review and Pooled Analysis of Interventional Studies
Audrey A. Jacobsen et al.
JAMA DERMATOLOGY (2016)
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
Gerald S. Falchook et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
The Impact of Neoadjuvant Hedgehog Inhibitor Therapy on the Surgical Treatment of Extensive Basal Cell Carcinoma
Jessica A. Ching et al.
ANNALS OF PLASTIC SURGERY (2015)
Induction Hedgehog pathway inhibition followed by combined-modality radiotherapy for basal cell carcinoma
D. R. Raleigh et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC
Aleksandar Sekulic et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Efficacy of Vismodegib (Erivedge) for Basal Cell Carcinoma Involving the Orbit and Periocular Area
Hakan Demirci et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2015)
Concurrent Vismodegib and Radiotherapy for Recurrent, Advanced Basal Cell Carcinoma
Erqi L. Pollom et al.
JAMA DERMATOLOGY (2015)
Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib
Anne Lynn S. Chang et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma
Mina Sarah Ally et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Surgical Excision After Neoadjuvant Therapy With Vismodegib for a Locally Advanced Basal Cell Carcinoma and Resistant Basal Carcinomas in Gorlin Syndrome
Anne Lynn S. Chang et al.
JAMA DERMATOLOGY (2013)
Basal cell carcinoma
CSM Wong et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Share Paper
